PTEN Tumor-Suppressor: The Dam of Stemness in Cancer

PTEN is one of the most frequently inactivated tumor suppressor genes in cancer. Loss or variation in PTEN gene/protein levels is commonly observed in a broad spectrum of human cancers, while germline PTEN mutations cause inherited syndromes that lead to increased risk of tumors. PTEN restrains tumorigenesis through different mechanisms ranging from phosphatase-dependent and independent activities, subcellular localization and protein interaction, modulating a broad array of cellular functions including growth, proliferation, survival, DNA repair, and cell motility. The main target of PTEN phosphatase activity is one of the most significant cell growth and pro-survival signaling pathway in cancer: PI3K/AKT/mTOR. Several shreds of evidence shed light on the critical role of PTEN in normal and cancer stem cells (CSCs) homeostasis, with its loss fostering the CSC compartment in both solid and hematologic malignancies. CSCs are responsible for tumor propagation, metastatic spread, resistance to therapy, and relapse. Thus, understanding how alterations of PTEN levels affect CSC hallmarks could be crucial for the development of successful therapeutic approaches. Here, we discuss the most significant findings on PTEN-mediated control of CSC state. We aim to unravel the role of PTEN in the regulation of key mechanisms specific for CSCs, such as self-renewal, quiescence/cell cycle, Epithelial-to-Mesenchymal-Transition (EMT), with a particular focus on PTEN-based therapy resistance mechanisms and their exploitation for novel therapeutic approaches in cancer treatment.

• Publication year

  2019

• Venue

  Cancers

• Publication date

  2019-07-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3390/cancers11081076PMID 31366089PMCID 6721423
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PTEN Genetic and Epigenetic Alterations Define Distinct Subgroups in North Indian Breast Cancer Patients

  2019cited by this paper
• PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise?

  2019cited by this paper
• Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway

  2019cited by this paper
• PTEN Methylation by NSD2 Controls Cellular Sensitivity to DNA Damage.

  2019cited by this paper
• LncRNAs-directed PTEN enzymatic switch governs epithelial–mesenchymal transition

  2019cited by this paper
• Cancer Stem Cells: The Architects of the Tumor Ecosystem.

  2019cited by this paper
• Nuclear PTEN safeguards pre-mRNA splicing to link Golgi apparatus for its tumor suppressive role

  2018cited by this paper
• The functions and regulation of the PTEN tumour suppressor: new modes and prospects

  2018influential reference
• T-ALL leukemia stem cell 'stemness' is epigenetically controlled by the master regulator SPI1

  2018cited by this paper
• mTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53

  2018cited by this paper
• Replication stress response in cancer stem cells as a target for chemotherapy.

  2018cited by this paper
• Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate

  2018influential reference
• Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival

  2018cited by this paper
• Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation

  2017cited by this paper
• PTENβ is an alternatively translated isoform of PTEN that regulates rDNA transcription

  2017cited by this paper
• Inhibition of miR-23a increases the sensitivity of lung cancer stem cells to erlotinib through PTEN/PI3K/Akt pathway.

  2017cited by this paper
• Engineering PTEN-L for Cell-Mediated Delivery

  2017cited by this paper
• Cancer stem cells revisited

  2017cited by this paper
• Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment

  2017cited by this paper
• PRMT5–PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells

  2017cited by this paper
• Molecular Testing in Patients With Castration-Resistant Prostate Cancer and Its Impact on Clinical Decision Making.

  2017cited by this paper
• Pharmacological inhibition of the transcription factor PU.1 in leukemia

  2017influential reference
• Cancer stem cells: at the forefront of personalized medicine and immunotherapy.

  2017cited by this paper
• Pten is necessary for the quiescence and maintenance of adult muscle stem cells

  2017cited by this paper
• Clinical Implications for Germline PTEN Spectrum Disorders.

  2017cited by this paper
• PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles

  2017cited by this paper
• PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer

  2017cited by this paper
• EMT, CSCs, and drug resistance: the mechanistic link and clinical implications

  2017cited by this paper
• A Short Region of Connexin43 Reduces Human Glioma Stem Cell Migration, Invasion, and Survival through Src, PTEN, and FAK

  2017influential reference
• miR-494-3p is a novel tumor driver of lung carcinogenesis

  2016cited by this paper
• Pten loss promotes MAPK pathway dependency in HER2/neu breast carcinomas

  2016influential reference
• Connexin43 recruits PTEN and Csk to inhibit c-Src activity in glioma cells and astrocytes

  2016cited by this paper
• Hypoxia-induced modulation of PTEN activity and EMT phenotypes in lung cancers

  2016cited by this paper
• miR‐10b expression in breast cancer stem cells supports self‐renewal through negative PTEN regulation and sustained AKT activation

  2016cited by this paper
• Dual Shp2 and Pten Deficiencies Promote Non-alcoholic Steatohepatitis and Genesis of Liver Tumor-Initiating Cells.

  2016cited by this paper
• PTEN opposes negative selection and enables oncogenic transformation of pre-B cells

  2016cited by this paper
• Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancer

  2016cited by this paper
• Stromal PTEN inhibits the expansion of mammary epithelial stem cells through Jagged-1

  2016cited by this paper
• Polycomb complex protein BMI-1 promotes invasion and metastasis of pancreatic cancer stem cells by activating PI3K/AKT signaling, an ex vivo, in vitro, and in vivo study

  2016cited by this paper
• PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma

  2016cited by this paper
• EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop

  2016influential reference
• miR-221/222 enhance the tumorigenicity of human breast cancer stem cells via modulation of PTEN/Akt pathway.

  2016cited by this paper
• An in vitro system to characterize prostate cancer progression identified signaling required for self‐renewal

  2016cited by this paper
• Molecular profiling of head and neck squamous cell carcinoma

  2015cited by this paper
• PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype

  2015cited by this paper
• The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells

  2015influential reference
• The Molecular Taxonomy of Primary Prostate Cancer.

  2015cited by this paper
• Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update

  2015cited by this paper
• Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.

  2015cited by this paper
• Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth

  2015cited by this paper
• Discovery and functional characterization of a neomorphic PTEN mutation

  2015cited by this paper
• MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer

  2015influential reference
• Trastuzumab resistance induces EMT to transform HER2+ PTEN− to a triple negative breast cancer that requires unique treatment options

  2015cited by this paper
• Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial

  2015cited by this paper
• Colorectal cancer stem cells: from the crypt to the clinic.

  2014cited by this paper
• Evolution of the cancer stem cell model.

  2014cited by this paper
• CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis.

  2014cited by this paper
• Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function.

  2014cited by this paper
• Tackling the cancer stem cells — what challenges do they pose?

  2014cited by this paper
• Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis.

  2014cited by this paper
• Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy

  2014cited by this paper
• PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events.

  2014cited by this paper
• Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity.

  2014cited by this paper
• PTENα, a PTEN isoform translated through alternative initiation, regulates mitochondrial function and energy metabolism.

  2014cited by this paper
• Targeting the MYC and PI3K pathways eliminates leukemia-initiating cells in T-cell acute lymphoblastic leukemia.

  2014influential reference
• Combined image and genomic analysis of high-grade serous ovarian cancer reveals PTEN loss as a common driver event and prognostic classifier

  2014cited by this paper
• PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting.

  2014cited by this paper
• PTEN expression is consistent in colorectal cancer primaries and metastases and associates with patient survival

  2013cited by this paper
• Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells

  2013cited by this paper
• PTEN mutation, methylation and expression in breast cancer patients

  2013cited by this paper
• Molecular regulation of stem cell quiescence

  2013cited by this paper
• Structure-dependent inhibition of the ETS-family transcription factor PU.1 by novel heterocyclic diamidines

  2013influential reference
• Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN

  2013cited by this paper
• Enrichment of ovarian cancer stem‐like cells is associated with epithelial to mesenchymal transition through an miRNA‐activated AKT pathway

  2013cited by this paper
• PTEN deficiency contributes to the development and progression of head and neck cancer.

  2013cited by this paper
• Involvement of TGFβ-Induced Phosphorylation of the PTEN C-Terminus on TGFβ-Induced Acquisition of Malignant Phenotypes in Lung Cancer Cells

  2013cited by this paper
• Dual Pten/Tp53 suppression promotes sarcoma progression by activating Notch signaling.

  2013cited by this paper
• The somatic genomic landscape of glioblastoma.

  2013cited by this paper
• A Secreted PTEN Phosphatase That Enters Cells to Alter Signaling and Survival

  2013cited by this paper
• The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through multiple mechanisms

  2012cited by this paper
• Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells.

  2012cited by this paper
• The impact of PTEN tumor suppressor gene on acquiring resistance to tamoxifen treatment in breast cancer patients

  2012cited by this paper
• Functional analysis of the protein phosphatase activity of PTEN

  2012cited by this paper
• Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation

  2012cited by this paper
• The functions and regulation of the PTEN tumour suppressor

  2012cited by this paper
• Loss of Phosphatase and Tensin Homolog Protein Expression Is an Independent Poor Prognostic Marker in Lung Adenocarcinoma

  2012cited by this paper
• Targeted therapy for hepatocellular carcinoma: novel agents on the horizon

  2012influential reference
• PTEN as a Prognostic and Predictive Marker in Postoperative Radiotherapy for Squamous Cell Cancer of the Head and Neck

  2012cited by this paper
• Compensatory pathways in oncogenic kinase signaling and resistance to targeted therapies: six degrees of separation.

  2012cited by this paper
• The Tumor Suppressor PTEN Is Exported in Exosomes and Has Phosphatase Activity in Recipient Cells

  2012cited by this paper
• Stress Response of Glioblastoma Cells Mediated by miR-17-5p Targeting PTEN and the Passenger Strand miR-17-3p Targeting MDM2

  2012influential reference
• PTEN Protein Phosphatase Activity Correlates with Control of Gene Expression and Invasion, a Tumor-Suppressing Phenotype, But Not with AKT Activity

  2012cited by this paper
• Hepatic transforming growth factor beta gives rise to tumor‐initiating cells and promotes liver cancer development

  2012influential reference
• A matter of life and death: self‐renewal in stem cells

  2012cited by this paper
• Improved classification of breast cancer by analysis of genetic alterations and gene expression profiling

  2011cited by this paper
• c‐Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma

  2011cited by this paper
• The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers.

  2011cited by this paper
• Lupeol targets liver tumor‐initiating cells through phosphatase and tensin homolog modulation

  2011cited by this paper
• Suppression of leukemia development caused by PTEN loss

  2011cited by this paper
• Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice.

  2011cited by this paper

• Immunomodulatory Phytochemicals in Cancer: Mechanistic Pathways and Translational Potential

  2026cites this paper
• Gene and cytokine expression profiles of metastatic colorectal cancer patients post reovirus administration

  2026cites this paper
• Combining Molecular Docking and Molecular Dynamics Simulation to Explore Quercetin's Affinity and Interactions with Wild-Type and Mutated Phosphatase and Tensin Homolog (PTEN)

  2026cites this paper
• Neuregulin induces prostate cancer cell migration via HER3/HER2-FAK/Src signaling axis

  2026cites this paper
• The hallmarks of oncogenic signaling: From pathways to resistance in cancer therapy.

  2026cites this paper
• Investigating the expression changes of several key genes in prostate cancer cells under exposure to the ELF pulsed electromagnetic fields

  2025cites this paper
• The Value of Punching It Out: Patient With Cowden Syndrome and MALT Lymphoma of the Lung

  2025cites this paper
• Critical regulatory roles of non-coding RNAs in driving cancer sensitivity to Carmustine: a systematic review

  2025cites this paper
• Current and Emerging Therapies for Targeting the ERK1/2 & PI3K Pathways in Cancer

  2025influential citation
• Human cerebral organoids model tumor initiation and infiltration in an autologous astrocyte-supported setting

  2025cites this paper
• Comprehensive analysis of oncogenic determinants across tumor types via multi-omics integration.

  2025cites this paper
• FOXO1 and FYN Expression Trends in Breast Cancer Stem Cells: An Integrative Study of Single Nucleotide Polymorphism (SNP) Array and Quantitative PCR (qPCR) Analysis

  2025cites this paper
• Dysregulation of the Cyclin D/E2F activity as a core mechanism driving cancer stem cell plasticity and cell cycle dynamics.

  2025cites this paper
• Cancer stem cells in hepatocellular carcinoma: therapy resistance and emerging treatments

  2025cites this paper
• The role of phytochemicals from traditional and medicinal plants in the treatment and inhibition of colon cancer exploring different pathways.

  2025cites this paper
• Isoliquiritigenin in Breast Cancer: A Systematic Review of Its Preventive and Anti-metastatic Mechanisms

  2025cites this paper
• Redox-Regulated Pathways in Glioblastoma Stem-like Cells: Mechanistic Insights and Therapeutic Implications

  2025cites this paper
• Exploring Phosphatase and Tensin Homologue Deleted on Chromosome Ten (PTEN) as a Potential Therapeutic Target for Cardiac Hypertrophy.

  2025cites this paper
• AKT inhibitors in gynecologic oncology: past, present and future

  2025cites this paper
• Peptide inhibitors: Breaking cancer code.

  2025cites this paper
• PI3 K/AKT/mTOR pathway and its role in breast cancer stem cells

  2025influential citation
• Cinnamic acid enhances vinorelbine-induced cytotoxicity in MDA-MB-231 cells through modulation of PTEN and ATG5 expression.

  2025cites this paper
• Unraveling the Hippo pathway: YAP/TAZ as central players in cancer metastasis and drug resistance

  2025cites this paper
• Widespread activation and critical role of EMT and stemness in the neuroendocrine differentiation of prostate cancer (Review)

  2025cites this paper
• Exosomal delivery of non-coding RNAs: a pathway to apoptosis regulation in lung cancer

  2025cites this paper
• Exploring the chemotherapeutic potential of diosmetin ruthenium-p-cymene complex in bladder cancer treatment through the regulation of the PI3K/β-catenin/TJP1/AR signaling pathway.

  2025cites this paper
• Unravelling chemotherapeutic activity of fisetin ruthenium-p-cymene complex in lung cancer treatment by the modulation of GRB2/RAS/MEK/DNMT1 signaling pathway

  2025cites this paper
• Comprehensive computational analysis of deleterious nsSNPs in PTEN gene for structural and functional insights

  2025cites this paper
• Role of tumor suppressor genes P53 and PTEN in CD44-mediated gastric adenocarcinoma multidrug resistance.

  2025cites this paper
• MicroRNA-34a enhances immune response and suppresses PI3K/AKT signaling through targeting PD-L1 in triple-negative breast cancer

  2025cites this paper
• Proteomics and personalized PDX models identify treatment for a progressive malignancy within an actionable timeframe

  2025cites this paper
• The Impact of TRPM8 on Prostate Cancer Transcriptomic Dynamics

  2025cites this paper
• Recent advancement in the anticancer efficacy of the natural flavonoid scutellarin: a comprehensive review

  2025cites this paper
• Exploring the anticancer potential of Jerantinine A from Tabernaemontana coronaria against prostate, breast, and ovarian cancers: a computational approach

  2025cites this paper
• Role of noncoding RNA as a pacemaker in cancer stem cell regulation: a review article

  2025cites this paper
• PTEN-mediated resistance in cancer: From foundation to future therapies

  2025cites this paper
• Targeting PI3K in Cancer Treatment: A Comprehensive Review with Insights from Clinical Outcomes.

  2025cites this paper
• Helicobacter pylori, microbiota and gastric cancer — principles of microorganism-driven carcinogenesis

  2025cites this paper
• Beyond Phytic Acid: Nutrigenetic and Nutrigenomic Insights into Its Hydrolysis, Transport, and Metabolism

  2025cites this paper
• Plasma membrane and nuclear phosphatidylinositol 4,5-bisphosphate signalling in cancer

  2025cites this paper
• Molecular pathways in reproductive cancers: a focus on prostate and ovarian cancer

  2025cites this paper
• Comparative Analysis of PTEN, ER, and PR Expression in Invasive Versus Non-Invasive Breast Carcinoma Across Different Histological Grades in Local Population

  2024cites this paper
• MicroRNA-21's role in PTEN suppression and PI3K/AKT activation: Implications for cancer biology.

  2024cites this paper
• Prognostic Biomarkers in Evolving Melanoma Immunotherapy

  2024cites this paper
• Targeting PI3K/AKT/mTOR Signalling pathway in non-small-cell lung carcinoma: Exploring promising bioactive natural compounds as anti-cancer agents

  2024cites this paper
• Development and Clinical Applications of PI3K/AKT/mTOR Pathway Inhibitors as a Therapeutic Option for Leukemias.

  2024cites this paper
• AKT kinases as therapeutic targets

  2024cites this paper
• Unraveling the role of LncRNAs in glioblastoma progression: insights into signaling pathways and therapeutic potential

  2024cites this paper
• Next-generation sequencing uncovers crucial mutated genes and potential therapeutic targets in ovarian cancer patients.

  2024cites this paper
• BATF2 inhibits the stem cell-like properties and chemoresistance of gastric cancer cells through PTEN/AKT/β-catenin pathway

  2024cites this paper
• Theophylline derivatives promote primordial follicle activation via cAMP-PI3K/Akt pathway and ameliorate fertility deficits in naturally aged mice

  2024cites this paper
• Prostate Cancer Progression Modeling Provides Insight into Dynamic Molecular Changes Associated with Progressive Disease States

  2024cites this paper
• Brain insulin resistance in Down syndrome: Involvement of PI3K-Akt/mTOR axis in early-onset of Alzheimer's disease and its potential as a therapeutic target.

  2024cites this paper
• NHEJ is promoted by the phosphorylation and phosphatase activity of PTEN via regulation of DNA-PKcs.

  2024cites this paper
• Piperine enhances doxorubicin sensitivity in triple-negative breast cancer by targeting the PI3K/Akt/mTOR pathway and cancer stem cells

  2024cites this paper
• Immunohistochemical Expression of PTEN in Canine Gliomas

  2024cites this paper
• Integrating molecular docking and molecular dynamics simulation approaches for investigation of the affinity and interactions of the Curcumin with phosphatase and tensin homolog (PTEN) and mutated PTEN

  2024cites this paper
• Proteomics and personalized patient-derived xenograft models identify treatment opportunities for a progressive malignancy within a clinically actionable timeframe and change care

  2024cites this paper
• From Tyrosine Kinases to Tyrosine Phosphatases: New Therapeutic Targets in Cancers and Beyond

  2024cites this paper
• A novel mutation in PTEN in anaplastic thyroid carcinoma: A case report

  2024cites this paper
• Hereditary Gastrointestinal Tumor Syndromes: When Risk Comes with Your Genes

  2024cites this paper
• Extracellular Vesicle-Mediated Modulation of Stem-like Phenotype in Breast Cancer Cells under Fluid Shear Stress

  2024cites this paper
• GINS1 Promotes the Initiation and Progression of Bladder Cancer by Activating the AKT/mTOR/c-Myc Signaling Pathway.

  2024cites this paper
• HOLOTHURIA SCABRA METHANOL EXTRACT INHIBITS CANCER GROWTH THROUGH TGF-β/PI3K/PTEN SIGNALING PATHWAY IN BREAST CANCER MICE MODEL.

  2024cites this paper
• High glucose-induced downregulation of PTEN-Long is sufficient for proximal tubular cell injury in diabetic kidney disease.

  2024cites this paper
• Landscape of Endometrial Cancer: Molecular Mechanisms, Biomarkers, and Target Therapy

  2024cites this paper
• Insights into Clinical Disorders in Cowden Syndrome: A Comprehensive Review

  2024cites this paper
• Regulation of Hypoxia Dependent Reprogramming of Cancer Metabolism: Role of HIF-1 and Its Potential Therapeutic Implications in Leukemia

  2024cites this paper
• The PI3K/AKT/mTOR signaling pathway in breast cancer: Review of clinical trials and latest advances

  2024cites this paper
• Decoding the regulatory landscape of lncRNAs as potential diagnostic and prognostic biomarkers for gastric and colorectal cancers

  2024cites this paper
• Bi-omics prognostic model for invasive ductal carcinoma using deep learning

  2023cites this paper
• Molecular aspects of brain metastases in breast cancer.

  2023cites this paper
• Interfering with the Ubiquitin-Mediated Regulation of Akt as a Strategy for Cancer Treatment

  2023cites this paper
• A novel PTEN mutant caused by polymorphism in cis-regulatory elements is involved in chemosensitivity in breast cancer.

  2023cites this paper
• Treatment of PTEN-null breast cancer by a synthetic lethal approach involving PARP1 gene silencing.

  2023cites this paper
• Mechanisms of cancer cell death induction by triptolide

  2023cites this paper
• MiR-328-3p promotes TGF-β1-induced proliferation, migration, and inflammation of airway smooth muscle cells by regulating the PTEN/Akt pathway.

  2023cites this paper
• circSOBP Inhibits Bladder Cancer Proliferation and Metastasis by Regulating the miR-200a-3p/PTEN Axis and Participating in the Immune Response

  2023cites this paper
• The Role of Genetic Mutations in Mitochondrial-Driven Cancer Growth in Selected Tumors: Breast and Gynecological Malignancies

  2023cites this paper
• Current status and future trends of reconstructing a vascularized tissue-engineered trachea

  2023cites this paper
• LOXL1-AS1/miR-761/PTEN as a Novel Signaling Pathway in Myocardial Ischemia and Reperfusion Injury (MIRI): Epigenetic Regulation by Long Non-Coding RNA (LncRNA) in MIRI

  2023cites this paper
• Preoperative fibrinogen is associated with the clinical survival of primary liver cancer patients and promotes hepatoma metastasis via the PTEN/AKT/mTOR pathway

  2023cites this paper
• Hindquarter Amputation as a Successful Treatment of Chronic Pain in an Adolescent with PTEN Hamartoma Tumor Syndrome

  2023cites this paper
• PTEN is both an activator and a substrate of chaperone-mediated autophagy

  2023cites this paper
• The potential role of miRNAs in the pathogenesis of gallbladder cancer - A focus on signaling pathways interplay.

  2023cites this paper
• PTEN-related risk classification models for predicting prognosis and immunotherapy response of hepatocellular carcinoma

  2023cites this paper
• Therapeutic Implications of PTEN in Non-Small Cell Lung Cancer

  2023cites this paper
• Lipid Nanoparticles Optimized for Targeting and Release of Nucleic Acid

  2023cites this paper
• Aberrant PI3Kδ splice isoform as a potential biomarker and novel therapeutic target for endocrine cancers

  2023cites this paper
• The emerging role of lipid nanosystems and nanomicelles in liver diseases.

  2023cites this paper
• PTEN/AKT and Wnt/β-catenin signaling pathways regulate the proliferation of Lgr5+ cells in liver cancer.

  2023cites this paper
• Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Taxus chinensis against non-small cell lung cancer

  2023cites this paper
• Unlocking New Avenues in Breast Cancer Treatment: The Synergy of Kinase Inhibitors and Immunotherapy

  2023cites this paper
• Spectroscopy and molecular simulation on the interaction of Nano-Kaempferol prepared by oil-in-water with two carrier proteins: An investigation of protein-protein interaction.

  2023cites this paper
• Helicobacter pylori-Induced Host Cell DNA Damage and Genetics of Gastric Cancer Development.

  2023cites this paper
• Exosomes: A novel insight into traditional Chinese medicine

  2022cites this paper
• The impact of TP53 and PTEN tumor suppressor genes on response to different breast cancer treatment modalities

  2022cites this paper
• miR-382-5p promotes cell invasion in hepatocellular carcinoma by targeting PTEN to activate PI3K/Akt signaling pathway

  2022cites this paper
• Andrographolide Exhibits Anticancer Activity against Breast Cancer Cells (MCF-7 and MDA-MB-231 Cells) through Suppressing Cell Proliferation and Inducing Cell Apoptosis via Inactivation of ER-α Receptor and PI3K/AKT/mTOR Signaling

  2022cites this paper
• Signaling pathways governing glioma cancer stem cells behavior.

  2022cites this paper